Thomas Chalopin

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

Gaëlle Fossard, Florence Broussais, Inês Coelho et al. · Annals of Oncology · 2017 · 140 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Transplantation +7

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Xavier Leleu, Cyrille Hulin, Jérôme Lambert et al. · Nature Medicine · 2024 · 87 citations · Full text

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study

Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau et al. · Clinical Microbiology and Infection · 2024 · 46 citations · Full text

Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma

Aurore Perrot, Jérôme Lambert, Cyrille Hulin et al. · New England Journal of Medicine · 2025 · 33 citations

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial

Aurore Perrot, Cyrille Touzeau, Jérôme Lambert et al. · Blood · 2025 · 21 citations · Full text